Clinical Trials Related to C2N Diagnostics

Related studies linked through entity extraction aliases.

Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers

Status: RECRUITING
Phase: N/A

Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease

Status: WITHDRAWN
Phase: NA

Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Quality Improvement PrecivityAD Clinician Survey (QUIP I)

Status: COMPLETED
Phase: N/A

Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy

Status: COMPLETED
Phase: PHASE1